Creative Planning Allogene Therapeutics, Inc. Transaction History

Creative Planning

$101 Billion
Q3 2024

A detailed history of Creative Planning transactions in Allogene Therapeutics, Inc. stock. As of the latest transaction made, Creative Planning holds 61,396 shares of ALLO stock, worth $132,001. This represents 0.0% of its overall portfolio holdings.

Number of Shares

61,396

Previous 29,412 108.74%

Holding current value

$132,001

Previous $68,000 151.47%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 11, 2024	BUY	$2.08 - $3.5 $66,526 - $111,944	31,984 Added 108.74%	61,396 $171,000
Q2 2024 Aug 15, 2024	SELL	$2.23 - $4.38 $4,259 - $8,365	-1,910 Reduced 6.1%	29,412 $68,000
Q1 2024 May 10, 2024	BUY	$2.92 - $5.63 $8,795 - $16,957	3,012 Added 10.64%	31,322 $140,000
Q4 2023 Feb 14, 2024	SELL	$2.28 - $3.5 $12,063 - $18,518	-5,291 Reduced 15.75%	28,310 $90,000
Q3 2023 Nov 16, 2023	BUY	$3.17 - $5.96 $106,515 - $200,261	33,601 New	33,601 $106,000
Q1 2023 May 15, 2023	SELL	$4.92 - $8.21 $18,784 - $31,345	-3,818 Reduced 12.39%	27,000 $133,000
Q4 2022 Feb 10, 2023	BUY	$5.62 - $11.11 $522 - $1,033	93 Added 0.3%	30,818 $193,000
Q3 2022 Nov 03, 2022	BUY	$10.32 - $17.28 $123 - $207	12 Added 0.04%	30,725 $332,000
Q2 2022 Aug 15, 2022	BUY	$6.78 - $12.28 $34,666 - $62,787	5,113 Added 19.97%	30,713 $350,000
Q1 2022 May 16, 2022	SELL	$7.65 - $15.29 $504 - $1,009	-66 Reduced 0.26%	25,600 $233,000
Q4 2021 Feb 11, 2022	BUY	$13.13 - $24.52 $866 - $1,618	66 Added 0.26%	25,666 $383,000
Q2 2021 Aug 04, 2021	BUY	$23.49 - $35.8 $5,849 - $8,914	249 Added 0.98%	25,600 $668,000
Q1 2021 Apr 30, 2021	SELL	$25.79 - $39.02 $16,737 - $25,323	-649 Reduced 2.5%	25,351 $895,000
Q4 2020 Jan 29, 2021	SELL	$25.24 - $43.45 $3,785 - $6,517	-150 Reduced 0.57%	26,000 $656,000
Q3 2020 Nov 05, 2020	SELL	$32.38 - $44.96 $12,952 - $17,984	-400 Reduced 1.51%	26,150 $986,000
Q2 2020 Jul 23, 2020	BUY	$18.39 - $54.04 $10,114 - $29,722	550 Added 2.12%	26,550 $1.14 Million
Q3 2019 Nov 01, 2019	BUY	$26.11 - $32.99 $26,110 - $32,990	1,000 Added 4.0%	26,000 $709,000
Q1 2019 Apr 24, 2019	BUY	$24.82 - $32.54 $119,136 - $156,192	4,800 Added 23.76%	25,000 $723,000
Q4 2018 Feb 01, 2019	BUY	$22.5 - $33.3 $454,500 - $672,660	20,200 New	20,200 $544,000

Others Institutions Holding ALLO

# of Institutions

162

Shares Held

134M

Call Options Held

59.4K

Put Options Held

113K

View Full List

About Allogene Therapeutics, Inc.

Ticker ALLO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 143,807,008
Market Cap $309M
Description
Allogene Therapeutics, Inc., a clinical stage immuno-oncology company, develops and commercializes genetically engineered allogeneic T cell therapies for the treatment of cancer. It develops, manufactures, and commercializes UCART19, an allogeneic chimeric antigen receptor (CAR) T cell product candidate for the treatment of pediatric and adult p...

More about ALLO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Creative Planning, based on Form 13F filings with the SEC.

News

Stay updated on Creative Planning with notifications on news.

Account

Creative Planning Allogene Therapeutics, Inc. Transaction History